Publications

Found 6 results
Filters: Author is H. Zhu  [Clear All Filters]
2012
P. Li, Jia, J. W., Jiang, L. X., Zhu, H., Bai, L., Wang, J. B., Tang, X. M., and Pan, A. H., Event-specific qualitative and quantitative PCR detection of the GMO carnation (Dianthus caryophyllus) variety Moonlite based upon the 5'-transgene integration sequence, vol. 11. pp. 1117-1129, 2012.
Berdal KG and Holst-Jensen A (2001). Roundup Ready® soybean event-specific real-time quantitative PCR assay and estimation of the practical detection and quantification limits in GMO analyses. Eur. Food Res. Technol. 213: 432-438. http://dx.doi.org/10.1007/s002170100403   Bird R (1994). Border Pinks. Timber Press, Portland.   Center for Food Safety (2006). Genetically Engineered Crops and Foods: Worldwide Regulation and Prohibition. Available at [http://www.centerforfoodsafety.org/pubs/World_Regs_Chart%20_6-2006.pdf]. Accessed April 11, 2011.   Department of Health and Ageing Office of the Gene Technology Requlator AG (2005). The Biology and Ecology of Dianthus Caryophyllus L. (Carnation). Available at [http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/content/carnation-3/$FILE/biologycarnation.pdf]. Accessed April 11, 2011.   European Commission (2003a). Commission regulation (EC) No. 1829/2003 of September 22, 2003, concerning on genetically modified food and feed. Off. J. Eur. Commun. L268: 1-23.   European Commission (2003b). Commission regulation (EC) No. 1830/2003 of September 22, 2003, concerning the traceability of food and feed products produced from genetically modified organisms and amending directive2001/18/ EC. Off. J. Eur. Commun. L268: 24-28.   European Network of GMO Laboratories (ENGL) (2008). Definition of Minimum Performance Requirements for Analytical Methods of GMO Testing. Available at [http://gmo-crl.jrc.ec. Europa.eu/doc/Min_Perf_Requirements_Analytical_methods.pdf]. Accessed April 16, 2011.   Guo J, Yang L, Liu X, Guan X, et al. (2009). Characterization of the exogenous insert and development of event-specific PCR detection methods for genetically modified Huanong No. 1 papaya. J. Agric. Food Chem. 57: 7205-7212. http://dx.doi.org/10.1021/jf901198x PMid:19645503   Holst-Jensen A, Ronning SB, Lovseth A and Berdal KG (2003). PCR technology for screening and quantification of genetically modified organisms (GMOs). Anal Bioanal. Chem. 375: 985-993. PMid:12733008   Hu J, Gu QX and Chi J (2004). Carnation Production Technology. China Agricultural Press, Beijing.   Hupfer C, Hotzel H, Sachse K and Engel KH (1998). Detection of the genetic modification in heat-treated products of Bt maize by polymerase chain reaction. Lebensm Unters Forsch. 206: 203-207. http://dx.doi.org/10.1007/s002170050243   James C (2010). Global Status of Commercialized Biotech/GM Crops. ISAAA Brief 42-2010 M. New York, USA: The International Service for the Acquisition of Agri-biotech Applications. Available at [http://www.isaaa.org]. Accessed April 11, 2011.   Jankiewicz A, Broll H and Zagon J (1999). The official method for the detection of genetically modified soybeans: A semi-quantitative study of sensitivity limits with glyphosate-tolerant soybeans (Roundup Ready) and insect-resistant Bt maize (Maximizer). Eur. Food Res. Technol. 209: 77-82. http://dx.doi.org/10.1007/s002170050461   Jiang L, Yang L, Rao J, Guo J, et al. (2010). Development and in-house validation of the event-specific qualitative and quantitative PCR detection methods for genetically modified cotton MON15985. J. Sci. Food Agric. 90: 402-408. PMid:20355060   Kahl LS (1994). Summary of Consultation with Calgene, Inc. Concerning FLAVR SAVRTM Tomato. FDA, Docket No. 91A20330.   Kim HY, Kim JH and Oh MH (2010). Regulation and detection methods for genetically modified foods in Korea. Pure Appl. Chem. 82: 129-137. http://dx.doi.org/10.1351/PAC-CON-09-01-21   Lee SH, Yi BY and Kim SJ (2009). Event-specific analytical methods for biotech maize MIR 604 and DAS-59122-7. J. Sci. Food Agric. 89: 2616-2624. http://dx.doi.org/10.1002/jsfa.3764   Liu YG, Mitsukawa N, Oosumi T and Whittier RF (1995). Efficient isolation and mapping of Arabidopsis thaliana T-DNA insert junctions by thermal asymmetric interlaced PCR. Plant J. 8: 457-463. http://dx.doi.org/10.1046/j.1365-313X.1995.08030457.x PMid:7550382   Matsuoka T (2001). GMO Labeling and Detection Methods in Japan. APEC-JIRCAS Joint Symposium and Workshop on Agriculture Biotechnology, September 6, Bangkok, Thailand. JIRCAS, Tsukuba.   Ministry of Agriculture and Forestry (2000). Guidelines for Labeling of Genetically Modified Agriculture Products. MAF Notification 2000-31. Ministry of Agriculture and Forestry, Korea.   Royal Bbotanic Gardens Kew (2005). Plant c-DNA Value Database (Release 4.0, October 2005). Available at [http://www.rbgkew.org.uk/cval/homepage.html]. Accessed April 11, 2011.   Wu G, Wu YH, Xiao L and Lu CM (2008). Event-specific qualitative and quantitative PCR methods for the detection of genetically modified rapeseed Oxy-235. Transgenic Res. 17: 851-861. http://dx.doi.org/10.1007/s11248-008-9168-5 PMid:18283554   Wu G, Wu YH, Xiao L and Lu CM (2009). Event-specific qualitative and quantitative PCR detection of genetically modified rapeseed Topas 19/2. Food Chem. 112: 232-238. http://dx.doi.org/10.1016/j.foodchem.2008.05.105   Yang L, Xu S, Pan A, Yin C, et al. (2005). Event specific qualitative and quantitative polymerase chain reaction detection of genetically modified MON863 maize based on the 5'-transgene integration sequence. J. Agric. Food Chem. 53: 9312-9318. http://dx.doi.org/10.1021/jf051782o PMid:16302741   Zhu H, Jiang LX, Tao SR, Li HY, et al. (2011). Validation of a carnation-specific gene, ANS, used as an endogenous reference gene in qualitative and real-time quantitative PCR for transgenic carnations. J. AOAC int. 94: 1227-1232. PMid:21919356
W. G. Zhong, Wang, Y., Zhu, H., and Zhao, X., Meta analysis of angiotensin-converting enzyme I/D polymorphism as a risk factor for preeclampsia in Chinese women, vol. 11, pp. 2268-2276, 2012.
Admiraal PJ, Derkx FH, Danser AH, Pieterman H, et al. (1990). Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 15: 44-55. http://dx.doi.org/10.1161/01.HYP.15.1.44 PMid:2403979   Bai H, Liu X, Liu R, Liu Y, et al. (2002). Angiotensinogen and angiotensin-I converting enzyme gene variations in Chinese pregnancy induced hypertension. Hua Xi Yi Ke Da Xue Xue Bao 33: 233-237. PMid:12575194   Bouba I, Makrydimas G, Kalaitzidis R, Lolis DE, et al. (2003). Interaction between the polymorphisms of the renin-angiotensin system in preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 110: 8-11. http://dx.doi.org/10.1016/S0301-2115(03)00046-0   Chen B, Zhuo J and Zhou L (2006). Study on the polymorphism of angiotensin I-converting enzyme gene in pregnancy•induced hypertension syndrome. Iian Yan Yi Xue 21: 39-41.   Deng W, Shi B, He X, Zhang Z, et al. (2004). Evolution and migration history of the Chinese population inferred from Chinese Y-chromosome evidence. J. Hum. Genet. 49: 339-348. http://dx.doi.org/10.1007/s10038-004-0154-3 PMid:15173934   Esplin MS, Fausett MB, Fraser A, Kerber R, et al. (2001). Paternal and maternal components of the predisposition to preeclampsia. N. Engl. J. Med. 344: 867-872. http://dx.doi.org/10.1056/NEJM200103223441201 PMid:11259719   Galao AO, de Souza LH, da Costa BE, Scheibe RM, et al. (2004). Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy. Am. J. Obstet. Gynecol. 191: 821-824. http://dx.doi.org/10.1016/j.ajog.2004.01.047 PMid:15467548   Gao Y, Qiu X, Ye F, Chen L, et al. (2002). Research on the deletion/insertion polymorphism of angiotensin converting enzyme gene in pregnancy induced hypertension women. Zhong Guo Fu You Bao Jian 17: 738-740.   He G, Liu X, Fan P, Liu R, et al. (2009). The C825T polymorphism in the G-protein beta 3 subunit gene in Chinese patients with preeclampsia. Hypertens. Pregnancy 28: 156-167. http://dx.doi.org/10.1080/10641950802366245 PMid:19437226   Huang Y, Liao B and Sun X (2001). Study on the relation between the angiotensin converting enzyme gene and pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 36: 15-17. PMid:11778536   Kaur R, Jain V, Khuller M, Gupta I, et al. (2005). Association of angiotensin-converting enzyme gene polymorphism with pregnancy-induced hypertension. Acta Obstet. Gynecol. Scand. 84: 929-933. PMid:16167906   Mao W, Li K and Zhao Y (2004). Study on MTHFR gene and ACE gene polymorphisms in pregnancy-induced hypertension. Chin. J. Perinat. Med. 7: 24.   Niu W and Qi Y (2011). Association of alpha-adducin and G-protein beta3 genetic polymorphisms with hypertension: a meta-analysis of Chinese populations. PLoS One 6: e17052. http://dx.doi.org/10.1371/journal.pone.0017052 PMid:21364877 PMCid:3045422   Rohacs T, Nagy G and Spat A (1997). Cytoplasmic Ca2+ signalling and reduction of mitochondrial pyridine nucleotides in adrenal glomerulosa cells in response to K+, angiotensin II and vasopressin. Biochem. J. 322 (Pt 3): 785-792. PMid:9148750 PMCid:1218256   Salimi S, Mokhtari M, Yaghmaei M, Jamshidi M, et al. (2011). Association of angiotensin-converting enzyme intron 16 insertion/deletion and angiotensin II type 1 receptor A1166C gene polymorphisms with preeclampsia in South East of Iran. J. Biomed. Biotechnol. 2011: 941515. http://dx.doi.org/10.1155/2011/941515 PMid:21808598 PMCid:3144719   Schmieder RE, Hilgers KF, Schlaich MP and Schmidt BM (2007). Renin-angiotensin system and cardiovascular risk. Lancet 369: 1208-1219. http://dx.doi.org/10.1016/S0140-6736(07)60242-6   Serrano NC, Diaz LA, Paez MC, Mesa CM, et al. (2006). Angiotensin-converting enzyme I/D polymorphism and preeclampsia risk: evidence of small-study bias. PLoS Med. 3: e520. http://dx.doi.org/10.1371/journal.pmed.0030520 PMid:17194198 PMCid:1716194   Shang T, Wang Y, Sun W and Sun F (2003). Relationship of ACE and AT1R and pregnancy induced hypertension. Chin. J. Obstet. Gynecol. 33: 102-103.   Tan CY, Chong YS, Loganath A, Chan YH, et al. (2009). Possible gene-gene interaction of KIR2DL4 with its cognate ligand HLA-G in modulating risk for preeclampsia. Reprod. Sci. 16: 1135-1143. http://dx.doi.org/10.1177/1933719109342280 PMid:19700612   Tiret L, Rigat B, Visvikis S, Breda C, et al. (1992). Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am. J. Hum. Genet. 51: 197-205. PMid:1319114 PMCid:1682892   Vefring HK, Wee L, Jugessur A, Gjessing HK, et al. (2010). Maternal angiotensinogen (AGT) haplotypes, fetal renin (REN) haplotypes and risk of preeclampsia; estimation of gene-gene interaction from family-triad data. BMC Med. Genet. 11: 90. http://dx.doi.org/10.1186/1471-2350-11-90 PMid:20537141 PMCid:2901215   Wang J, Bu T, Wang Y and Cheng P (2004). Relationship between insertion/deletion polymorphism of angiotensin converting enzyme gene and pregnancy-induced hypertension syndrome. Tian Jin Yi Yao 32: 339-341.   WHO (2005). World Health Report: Make Every Mother, and Child Count. World Health Organization, Geneva.   Wu Y, Cheng K, Su H, Cheng X, et al. (2002). Association of angiotensin converting enzyme polymorphism and preeclampsia. Zhonghua Fu Chan Ke Za Zhi 37: 301.   Yan W, Kulane A, Xiang P, Li Z, et al. (2011). Maternal and fetal angiotensin-converting enzyme gene insertion/deletion polymorphism not associated with pregnancy-induced hypertension in Chinese women. J. Matern. Fetal Neonatal Med. 24: 1119-1123. http://dx.doi.org/10.3109/14767058.2010.546452 PMid:21250908   Zhou N, Yu P, Chen J, Huang H, et al. (1999). Detection of insertion/deletion polymorphism of angiotensin converting enzyme gene in preeclampsia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 16: 29-31. PMid:9949238   Zhu M, Xia Y and Cheng W (1998). Study on a deletion polymorphism of the angiotensin converting enzyme gene in pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 33: 83-85. PMid:10682425